From Our Partners
Friday, July 1, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Medical Countermeasures

Seattle BioMed Rebrands as Center for Infectious Disease Research

by Global Biodefense Staff
April 28, 2015
Seattle BioMed Rebrands as Center for Infectious Disease Research

Seattle BioMed, a South Lake Union-based nonprofit which conducts infectious disease research, announced today the organization has rebranded as the Center for Infectious Disease Research.

“Our 250 scientists and staff work tirelessly every day to make scientific breakthroughs that lead to the prevention and treatment of infectious diseases across the globe”

“We’re excited to enter the next chapter in our organization’s history,” said Alan Aderem, PhD, president and director of the Center for Infectious Disease Research. “Our new brand represents the purpose, promise and global reach of our organization and betters position us to raise public awareness and support for the critical, life-saving research that is essential to improving health and saving lives.”

14 million people lose their lives every year to infectious diseases. The Center for Infectious Disease Research focuses on making transformative scientific advancements in the development of vaccines, drugs and diagnostics to treat and prevent HIV/AIDS, malaria, tuberculosis and other emerging and neglected diseases.

“Our 250 scientists and staff work tirelessly every day to make scientific breakthroughs that lead to the prevention and treatment of infectious diseases across the globe,” said John Aitchison, PhD, scientific director of the Center for Infectious Disease Research.

The organization is officially introducing the new name and brand to the public on Thursday, April 30 at an event in Seattle. The event will feature speeches from Washington Gov. Jay Inslee, King County Councilmember Joe McDermott, Ana Mari Cauce, interim president of the University of Washington and a coalition of global health leaders including Lisa Cohen, executive director of Washington Global Health Alliance and Allan Jones, CEO of the Allen Institute for Brain Science, discussing the need to increase funding for the National Institutes of Health.

“With so much work still to be done, it is important we use our public brand launch to highlight the critical funding challenges facing the National Institutes of Health,” said Dr. Aderem. “The NIH has seen its funding capacity drastically diminished in recent years and can now only fund one in six research requests. The stakes couldn’t be higher – there are millions of lives depending on new scientific breakthroughs, which require increased funding capacity.”

During the brand launch event, the Center for Infectious Disease Research and its coalition of global health organizations and leaders is launching a petition urging Congress to increase funding for the NIH.

From Our Partners

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC